Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Basal Cell Carcinoma Aggressiveness, Molecular Factors And Therapy: A Clinician Perspective

Basal Cell Carcinoma Aggressiveness, Molecular Factors And Therapy: A Clinician Perspective AbstractBasal cell carcinoma represents the most common skin and epithelial cancer. Most of the patients are cured by surgery. However, some cases display fullblown aggressiveness which has a dual connotation. The tumour may reach an impressive size being locally destructive while in rare cases, basal cell carcinomas may metastasize. If this agressivetumour is located on the face or neck, the surgeon is confronted with a clinical dilemma since total removal of the lesion with clear margins is impossible. Therefore, nonsurgical approaches need to be adopted in these cases. A better understand of the molecular pathways could theoretically lead to new improved therapeutic treatments. The current paper presents an update on the molecular factors with clinical importance for the treatment of basal cell carcinoma in parallel with presentation of an aggressive case as well as a review of the current therapeutic methods. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png ARS Medica Tomitana de Gruyter

Basal Cell Carcinoma Aggressiveness, Molecular Factors And Therapy: A Clinician Perspective

Loading next page...
 
/lp/de-gruyter/basal-cell-carcinoma-aggressiveness-molecular-factors-and-therapy-a-a8o4FROCF0
Publisher
de Gruyter
Copyright
© 2013
ISSN
1841-4036
eISSN
1841-4036
DOI
10.2478/v10307-012-0011-0
Publisher site
See Article on Publisher Site

Abstract

AbstractBasal cell carcinoma represents the most common skin and epithelial cancer. Most of the patients are cured by surgery. However, some cases display fullblown aggressiveness which has a dual connotation. The tumour may reach an impressive size being locally destructive while in rare cases, basal cell carcinomas may metastasize. If this agressivetumour is located on the face or neck, the surgeon is confronted with a clinical dilemma since total removal of the lesion with clear margins is impossible. Therefore, nonsurgical approaches need to be adopted in these cases. A better understand of the molecular pathways could theoretically lead to new improved therapeutic treatments. The current paper presents an update on the molecular factors with clinical importance for the treatment of basal cell carcinoma in parallel with presentation of an aggressive case as well as a review of the current therapeutic methods.

Journal

ARS Medica Tomitanade Gruyter

Published: Dec 1, 2012

References